Records containing: Sarcomatous Mesothelioma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-10-21A Phase II Trial of Novel Oral Anti-Angiogenic Agent AZD2171 (NSC-732208) in Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2014-12-29Phase II Study of PXD101 (NSC 726630) as Second-Line Therapy for Treatment of Patients With Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2014-02-11A Double Blind, Placebo Controlled Randomized Phase II Trial Of Gemcitabine And Cisplatin With Or Without The VEGF Inhibitor Bevacizumab (NSC #704865) In Patients With Malignant Mesotheloma
-
CLINICAL_TRIALS study record update · 2013-09-10Phase II Study of AZD2171 (NSC#732208) in Patients With Malignant Mesothelioma
-
CLINICAL_TRIALS study record update · 2013-08-02A Phase II Trial of AMG 102 in Combination With Pemetrexed and Cisplatin in Patients With Malignant Pleural Mesothelioma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-06-05A Phase II Study of BAY 43-9006 (NSC #724772) in Patients With Malignant Mesothelioma
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase II Study of Oral EGFR Tyrosine Kinase Inhibitor OSI-774 (NSC-718781) in Patients With Malignant Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2013-01-17A Phase II Study Of ZD 1839 (NSC 715055, IND 61187) In Patients With Malignant Mesothelioma